Diabetic Gastroparesis Archives - CINRX Pharma

CinDome Pharma Announces Completion of Enrollment in the envision^GI Phase 2 Study of Deudomperidone (CIN-102) for the Treatment of Idiopathic Gastroparesis

CinDome announces that the first participant has been dosed in the envisionGI Phase 2 clinical trial of deudomperidone (CIN-102) in adults with idiopathic gastroparesis.

CinDome Pharma Announces Enrollment Completion in the envision^3D Phase 2 Clinical Trial of Deudomperidone (CIN-102) for the Treatment of Diabetic Gastroparesis

Deudomperidone represents the first potential therapeutic for the long-term treatment of gastroparesis.

CinDome Pharma Announces First Patient Dosed in Clinical Trial of Deudomperidone (CIN-102)

CinDome announces that the first participant has been dosed in the envisionGI Phase 2 clinical trial of deudomperidone (CIN-102) in adults with idiopathic gastroparesis.